SurvivalGWAS_Power

SurvivalGWAS_Power calculates statistical power for detecting associations between single nucleotide polymorphisms (SNPs) and time-to-event (survival) outcomes to support the design of pharmacogenetic studies.


Key Features:

  • Time-to-Event Outcome Analysis: Handles time-to-event (survival) data for assessment of SNP associations with clinical outcomes over time.
  • Versatile Study Design Scenarios: Computes power across varying sample sizes, effect sizes, and other study parameters that influence power.
  • Analytical Flexibility: Supports analysis under the Cox proportional hazards model and Weibull regression model.
  • Treatment and Interaction Effects: Accounts for treatment effects and SNP × treatment interactions in power calculations.
  • Simulation Capabilities: Generates simulated datasets to evaluate power under complex or custom study scenarios.

Scientific Applications:

  • Pharmacogenetic study design: Enables design of studies to detect genetic determinants of drug response measured as time-to-event outcomes.
  • Power and sample size estimation: Estimates required sample sizes and detectable effect sizes for time-to-event genetic association studies.
  • Personalized medicine research: Informs identification of genetic influences on clinical outcomes over time to support therapeutic strategy development.

Methodology:

Calculates statistical power to detect associations between SNPs and time-to-event outcomes under various study conditions, incorporates Cox proportional hazards and Weibull regression models, and can generate simulated datasets.

Topics

Details

License:
GPL-3.0
Tool Type:
desktop application
Operating Systems:
Windows
Programming Languages:
C#
Added:
9/25/2018
Last Updated:
1/13/2019

Operations

Publications

Syed H, Jorgensen AL, Morris AP. SurvivalGWAS_Power: a user friendly tool for power calculations in pharmacogenetic studies with “time to event” outcomes. BMC Bioinformatics. 2016;17(1). doi:10.1186/s12859-016-1407-9. PMID:27931206. PMCID:PMC5146816.

PMID: 27931206
PMCID: PMC5146816
Funding: - Wellcome Trust: WT098017

Documentation